T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.79B |
| 2 |
PayPal
PYPL
|
+$1.64B |
| 3 |
Alibaba
BABA
|
+$1.46B |
| 4 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$1.11B |
| 5 |
Johnson Controls International
JCI
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$8.15B |
| 2 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$1.77B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.74B |
| 4 |
Danaher
DHR
|
+$1.54B |
| 5 |
GE Aerospace
GE
|
+$1.26B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.56% |
| 2 | Consumer Discretionary | 15.28% |
| 3 | Financials | 14.93% |
| 4 | Technology | 13.43% |
| 5 | Communication Services | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pfizer
PFE
$152B
| $3.16B | 0.64% |
98,356,516
-17,039,745
| -15% | -$570M |
|
27
Lowe's Companies
LOW
$124B
| $3.15B | 0.63% |
43,668,911
-1,173,290
| -3% | -$91.3M |
|
28
American Airlines Group
AAL
$10.1B
| $3.14B | 0.63% |
85,857,915
+2,634,064
| +3% | +$93.1M |
|
|
29
PayPal
PYPL
$50.5B
| $3.12B | 0.63% |
76,139,003
+42,783,928
| +128% | +$1.64B |
|
30
Becton Dickinson
BDX
$49.4B
| $3.03B | 0.61% |
17,269,556
+513,543
| +3% | +$87.8M |
|
|
AGN
31
DELISTED
Allergan plc
AGN
| $2.93B | 0.59% |
12,732,253
-3,858,522
| -23% | -$943M |
|
32
Comcast
CMCSA
$91B
| $2.91B | 0.58% |
87,584,110
+15,305,594
| +21% | +$509M |
|
33
PG&E
PCG
$38.1B
| $2.8B | 0.56% |
45,740,714
+5,434,388
| +13% | +$345M |
|
34
Intercontinental Exchange
ICE
$84.9B
| $2.62B | 0.53% |
48,599,525
-1,864,065
| -4% | -$102M |
|
35
State Street
STT
$51.4B
| $2.61B | 0.53% |
37,536,973
+3,594,037
| +11% | +$235M |
|
36
Roper Technologies
ROP
$39.5B
| $2.59B | 0.52% |
14,218,855
+961,508
| +7% | +$168M |
|
37
AutoZone
AZO
$49.7B
| $2.57B | 0.52% |
3,338,519
-8,108
| -0.2% | -$6.31M |
|
|
FISV
38
Fiserv Inc
FISV
$28B
| $2.56B | 0.52% |
51,564,314
-1,961,794
| -4% | -$103M |
|
|
39
GE Aerospace
GE
$382B
| $2.53B | 0.51% |
17,836,993
-8,456,067
| -32% | -$1.26B |
|
|
40
Johnson Controls International
JCI
$93.7B
| $2.45B | 0.49% |
52,726,629
+23,565,295
| +81% | +$1.09B |
|
|
41
Bristol-Myers Squibb
BMY
$130B
| $2.43B | 0.49% |
45,139,774
-27,116,075
| -38% | -$1.74B |
|
|
BNY
42
Bank of New York Mellon
BNY
$109B
| $2.39B | 0.48% |
59,936,589
-6,365,266
| -10% | -$254M |
|
43
Biogen
BIIB
$30.1B
| $2.38B | 0.48% |
7,610,028
+1,243,876
| +20% | +$368M |
|
|
ALXN
44
DELISTED
Alexion Pharmaceuticals
ALXN
| $2.37B | 0.48% |
19,364,434
-379,455
| -2% | -$48.8M |
|
45
PepsiCo
PEP
$189B
| $2.35B | 0.47% |
21,642,802
+3,773,486
| +21% | +$407M |
|
46
Humana
HUM
$44.8B
| $2.34B | 0.47% |
13,253,617
-613,956
| -4% | -$107M |
|
|
AMTD
47
DELISTED
TD Ameritrade Holding Corp
AMTD
| $2.3B | 0.46% |
65,314,557
-658,837
| -1% | -$20.5M |
|
48
O'Reilly Automotive
ORLY
$74.9B
| $2.23B | 0.45% |
119,459,010
+19,540,740
| +20% | +$366M |
|
49
Merck
MRK
$322B
| $2.23B | 0.45% |
37,380,123
+17,569,309
| +89% | +$1.03B |
|
50
Cisco
CSCO
$475B
| $2.22B | 0.45% |
69,860,968
+3,555,286
| +5% | +$109M |
|
Similar funds
T. Rowe Price Associates's Q3 2016 Portfolio in Review
As of Q3 2016, T. Rowe Price Associates held 2,648 positions worth $498B, up 5.4% from $472B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
T. Rowe Price Associates's Q3 2016 filing shows 135 new, 1,180 increased, 817 reduced and 125 closed positions. Its largest new stake was Fortive: 55,770,886 shares worth $1.79B. The largest sale was TotalEnergies, an estimated $8.15B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2016 buy was Fortive: 55,770,886 shares worth $1.79B.
- T. Rowe Price Associates added most to PayPal in Q3 2016, an estimated $1.64B increase.
- T. Rowe Price Associates's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $8.15B.
- T. Rowe Price Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $1.77B.
- T. Rowe Price Associates's ten largest holdings make up 17% of its $498B portfolio in Q3 2016.
- T. Rowe Price Associates opened 135 new positions and closed 125 in Q3 2016.
- T. Rowe Price Associates's portfolio value rose 5.4% quarter-over-quarter to $498B.
Based on T. Rowe Price Associates's 13F filing for Q3 2016, filed 14 Nov 2016.